Exploration of Blood Coagulation of N-Alkyl Chitosan Nanofiber

N-Alkylated chitosan (NACS) may improve the blood clotting efficiency of chitosan (CS). To study its blood coagulation capability, a series of NACSs w...
0 downloads 0 Views 3MB Size
Subscriber access provided by READING UNIV

Article

The exploration on blood coagulation of Nalkyl chitosan nanofiber membrane in vitro Xiaoyan Wang, Guan Jing, Xupin Zhuang, Zhihong Li, Shujie Huang, Jian Yang, Changjun Liu, Fan Li, Feng Tian, Jimin Wu, and Zhan Shu Biomacromolecules, Just Accepted Manuscript • DOI: 10.1021/acs.biomac.7b01492 • Publication Date (Web): 08 Jan 2018 Downloaded from http://pubs.acs.org on January 9, 2018

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

Biomacromolecules is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 17 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biomacromolecules

1

The exploration on blood coagulation of N-alkyl chitosan

2

nanofiber membrane in vitro

3

Xiaoyan Wang1,2, Jing Guan1*, XuPin Zhuang2*, Zhihong Li1, Shujie Huang1, Jian Yang1, ChangJun

4

Liu1, Fan Li1, Feng Tian1, Jimin Wu1, and Zhan Shu1.

5

1 Key laboratory of Medical Equipment, Academy of Military Medical Sciences, No. 106 Wandong

6

Road, Hedong District, Tianjin, 300161, China

7

2 Department of Textile, Tianjin Polytechnic University, No. 399 Binshui West Road, Xiqing District,

8

Tianjin, 300387, China.

9

Abstract:

10

N-alkylated chitosan (NACS) may improve blood clotting efficiency of chitosan (CS). To study its

11

blood coagulation capability, a series of NACS with various carbon chain lengths and degrees of

12

substitution (DS) of alkyl groups were synthesized and characterized by FTIR, NMR, elemental

13

analysis, and X-Ray diffraction (XRD). The corresponding NACS nanofiber membranes (NACS-NM)

14

were subsequently fabricated by electronic spinning technique. SEM, XRD, DSC, surface area,

15

porosity, contact angle, blood absorption and mechanical property were used to characterize the basic

16

property of CS-NM/NACS-NM. Moreover, cytotoxicity assay, coagulation, activated partial

17

thromboplastin time, plasma prothrombin time, thrombin time, and platelet aggregation tests were

18

performed to evaluate the biocompatibility and blood coagulation property of NACS-NM. The result

19

showed that NACS-NM was no cytotoxic. NACS-NM with DS of 19.25% for N-hexane CS (CS6b),

20

17.87% for N-dodecane CS (CS12b), and 8.97% for N-octadecane CS (CS18a) exhibited good blood

21

clotting performance. Moreover, NACS-NMs favored the activation of coagulation factors and platelets.

22

In addition, intracellular Ca2+ was not related to platelet activation. Above results suggested that NACS-

23

NM would be an effective hemostatic agent.

24

Keywords: N-alkyl chitosan, Nanofiber membrane, Coagulation, Cytotoxicity, Platelet.

25

1.INTRODUCTION

26

Uncontrolled trauma hemorrhage, one of the three major causes of unpreventable death, causes high

27

mortality rate and severe complications, Statistics data shows that more than 85% of the deaths is from

28

potentially survivable wounds in battlefields and more than half of trauma-related deaths in civilian

29

mortalities1-2. Hence, developing effective hemostatic agents is considerably important. Topical

30

hemostatic agents that are recently available include oxidized cellulose fabrics, absorbable gelatin

31

sponge, fibrin glue, topical thrombin and microfibrillar collagen powder. However, each product has

32

exhibited potential drawbacks so that no single product has dominantly emerged as preference3.

33

Therefore, safe, fast, and effective hemostatic materials still need investigating.

34

Chitosan (CS), β-(1-4) linked 2-amino-2-deoxy-β-D-glucopyranose, is a N-deacetylated derivative of

35

chitin obtained by transforming the acetamide groups into primary amino groups4. CS shows good

36

biocompatibility, tissue regeneration, antibacterial, anti-inflammatory and hemostatic properties5,

ACS Paragon Plus Environment

Biomacromolecules 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

37

which involves the agglutination of blood proteins and platelet activation for encouraging fibrin clot

38

formation6. Previous work proved that CS derivatives prepared by grafting hydrophobic groups could

39

improve hemostatic property greatly7-8. N-alkylated chitosan (NACS) becomes one of the most

40

desirable materials for fabrication of ideal hemostatic dressings because of its outstanding hemostatic

41

activity and excellent plugging ability to hemorrhaging wound surface9-11. NACS could transform

42

whole liquid blood into a gel quickly, and therefore it can stop bleeding rapidly from both minor and

43

severe injuries in small and large animals12. Further studies showed that NACS with suitable carbon

44

length and degree of substitution (DS) of alkyl groups could accelerate blood clotting significantly7.

45

Until now only four kinds of NACS-based hemostatic materials, namely, powder, sponge, foam, and

46

gauze, are currently available13-15. Nanofiber membrane (NM) is well known as possessing larger

47

surface area than above forms of materials due to its nanoscale size effect16-18, thus, NACS-NM could

48

have the potential suggested to accelerate platelet aggregation.

49

It’s commonly known that CS and its derivatives can be fabricated by electrospinning19-21, while

50

NACS-NM has not been fabricated publicly up to date. In the present study, we modified CS on -NH2

51

group and prepared CS-NM and NACS-NM as novel materials by electrospinning. The basic properties

52

of NACS were characterized by FTIR, NMR, elemental analysis and X-Ray diffraction (XRD), and

53

those of NACS-NMs were further assessed by SEM, XRD, DSC, surface area, porosity, contact angle,

54

blood absorption and mechanical properties. The cytotoxicity of NACS-NM was evaluated by MTT

55

and fluorescence labeling method. The clotting performance was subsequently measured by in vitro

56

coagulation time and thromboelastograph (TEG). Finally, the effect of NACS-NM on blood

57

components was assayed by blood plasma coagulation, platelet aggregation and intracellular Ca2+

58

concentration tests.

59

2.EXPERIMENTAL SECTION

60

2.1 Materials

61

CS (Huantai county golden shell products Co, Ltd, Zibo, Shandong, China), with high molecular

62

weight of 1.97×106 and deacetylation degree (DD) of 90.0%, was used without further purification.

63

Sodium hydroxide, ice acetic acid, ethanol, and other reagents were all of analytical grade. The

64

activated partial thromboplastin time (APTT), plasma prothrombin time (PT), and thrombin time (TT)

65

reagents and MTT kits were bought from Shanghai Sun biotechnology Co. Ltd. Hexane aldehyde,

66

dodecyl aldehyde, and octadecane aldehyde were purchased from Sigma (St. Louis, MO, USA).

67

Fluorescent reagents FITC, anti-P selectin, Fluo-4 AM, SYTO 9, and propidium iodide (PI) were

68

obtained from Invitrogen (Carlsbad, CA, USA).

69

2.2 Fabrication of CS-NM/NACS-NM

70

NACS was dissolved in acetic acid (90%, v/v) to prepare a solution of 1.5% (w/v), then the solution

ACS Paragon Plus Environment

Page 2 of 17

Page 3 of 17 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biomacromolecules

71

was moved into a 20mL syringe, with which a circular needle (inner diameter: 0.5 mm; length: 20 mm)

72

was connected. In addition, a syringe pump was applied to supply the solution to the needle at a rate of

73

1.5 mL/h and a collector was fixed at distance of 15 cm from the needle of syringe. During

74

electrospinning, the needle was submitted to a voltage of 25 kV. All the experiments were carried out at

75

room temperature under a humidity of less 30%. After electrospinning, the CS-NM/NACS-NM were

76

removed from the collector, dried in an oven at 60 ℃, and neutralized by an aqueous solution of K2CO3

77

for 2 h at 25 ℃. Subsequently, CS-NM/NACS-NM was washed with distilled water until pH 7 was

78

obtained and then vacuumed in an oven at 50 ℃ for 24 h.

79

2.3 The properties of CS-NM/NACS-NM

80

2.3.1 Morphology

81

The surface morphology of the CS-NM/NACS-NM were observed by SEM (S-4800, HITACH, Japan).

82

The diameters of fibers and their distributions in the CS-NM/NACS-NM were assessed by using the

83

image pro-plus software.

84

2.3.2 Crystallinity

85

The XRD patterns of CS-NM/NACS-NM were also determined according to the same method as the

86

CS/NACS. The thermal behavior of CS-NM and NACS-NM were characterized by differential

87

scanning calorimetry (DSC; DSC-200 F3, NETZSCH Company, Germany) in the temperature range of

88

30–600 °C at a heating rate of 10 °C/min.

89

2.3.3 Surface area and porosity

90

The surface area of CS-NM/NACS-NM was tested by automatic gas adsorption analyzer (Autosorb iQ,

91

America). Preprocessing parameters: decompression drying at 200 °C, 2 h, nitrogen gas for gas

92

absorption, absorption temperature of -196 °C. The porosity of CS-NM/NACS-NM was calculated by

93

referring the literature22-23.

94

2.3.4 Water contact angle and blood absorption

95

Contact angle was measured by a contact angle goniometer (JYSP-180, Jinshengxin Testing Machine

96

Co. Ltd., China). To evaluate the hydrophilic-hydrophobic property of CS-NM/NACS-NM, all of the

97

membranes were completely dried prior to measurement to avoid water interaction issue24. Then a 5.0

98

mL pure water droplet was placed onto the surface of CS-NM/NACS-NM using a microsyringe, after

99

which contact angle data were recorded by routine procedure. At least three readings from different

100

surface locations were obtained for each measurement.

101

A (2×2 cm2 CS-NM/NACS-NM) weight (Md) of nanofiber was immersed into the 1 mL anticoagulant

102

whole blood and soaked in the blood for 2 min. After that, the weight of the soaked nanofiber (Mw)

103

was measured using a balance. Each sample was tested three times. The blood absorption (A) of

104

nanofiber was calculated by the following equation:

105

A=

106

2.3.5 Mechanical property

107

The mechanical property of NM with a width of 1.5 mm and length of 14 mm was tested by an

108

electronic single-fiber strength tester. The test condition was: advance tension (0.4 cN), gauge length

ெೢ ିெ೏ ெ೏

× 100%

(1)

ACS Paragon Plus Environment

Biomacromolecules 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 4 of 17

109

(10 mm), stretching speed (10 mm/min). Each sample was tested three times.

110

2.4 Cytotoxicity

111

2.4.1 MTT

112

The in vitro cytotoxicity of NM was estimated by MTT assay according to ISO 10993-5. Samples

113

immersed in DMEM(6 cm2/mL)were kept in an incubator (5% CO2, 37 ℃) for 24 h, then the

114

samples were removed and the excess medium was named as liquid extract of experimental group.

115

Pure DMEM maintained under the same condition was named as liquid extract of control group. At the

116

same time, the human fibroblast cells (MRC5) were first seeded into 96-well plates at a seeding density

117

2×104 cells/mL and then incubated in DMEM supplemented with penicillin (100 U/mL), streptomycin

118

(100 g/L), and 10% fetal bovine serum overnight. Subsequently, the DMEM medium was replaced with

119

the liquid extract of the experiment/control group (100 µL). The cells were then cultured continuously

120

for 72 h. Afterwards, MTT solution (5 g/L) was added, and the cells were incubated for another 4 h.

121

Subsequently, the incubation medium was replaced with 150 µL of DMSO to dissolve the formazan

122

crystals. The amount of MTT-formazan complex was determined by measuring the absorbance of

123

dissolved crystals at 570 nm, with 655 nm as a reference7. The relative growth rate (RGR) was

124

calculated as follow:

125

RGR =

A ×100% A0

(2)

126

Where A is the difference of sample groups’ absorbance at 570 nm and 630 nm, and A0 is the difference

127

of control groups’ absorbance at 570 nm and 630 nm.

128

2.4.2 Live/dead assay

129

The live/dead double-staining method was introduced to determine the cytotoxicity of NACS-NM. The

130

MRC5 cells were incubated in liquid extract of experimental and control groups, which was similar to

131

the MTT assay. Then 10 µL of PI and SYTO 9 mixtures were added to stain the cells, after which the

132

cells were incubated at 37 °C for 15 min. Subsequently, the cells were observed and captured under a

133

fluorescence microscope (F-4600, Hitachi, Tokyo, Japan).

134

2.5 Blood coagulation properties of CS-NM/NACS-NM

135

All blood used in the following experiments was sampled from rabbits, which were bred by the Tianjin

136

medicine research institute. The anticoagulant whole blood was prepared according to the ratio of blood

137

to sodium citrate equaling 9:1(v/v).

138

2.5.1 Blood coagulation time (BCT)

139

First, 2×2 cm2 CS-NM/NACS-NM was placed in the test tube in a 37 ℃ water-bathing constant

140

temperature vibrator for 3 min. Anticoagulant whole blood (1 mL) was subsequently added into the

141

tube. After 1 min, 775 µL of CaCl2 (0.025mol/L) was added, and the time for blood clotting was then

ACS Paragon Plus Environment

Page 5 of 17 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biomacromolecules

142

recorded. The control group (blood only) was also evaluated by the same procedure. Each sample was

143

tested three times.

144

2.5.2 TEG

145

To monitor the whole dynamic process of thrombus forming, TEG was used to analyze the platelet

146

aggregation, blood coagulation, and fibrinolysis. First, 20 µL of CaCl2 (0.2 mol/L) solution was added

147

to the polyethylene cup. Afterward, 340 µL of mixed blood (experimental group, CS/NACS:

148

anticoagulant blood=10 mg: 1 mL) or pure blood (control group) was also added into the cup. The cup

149

was loaded then into defined position to collect data.

150

2.5.3 APTT, PT and TT

151

The test equipment is a semiautomatic blood coagulation analyzer (Clotec-II, Sysmex, Kobe, Japan).

152

First, the anticoagulant whole blood was centrifuged at 3000 rpm for 15 min. The supernatant was

153

drawn as platelet-poor plasma (PPP). In experimental groups, each CS-NM/NACS-NM (1×1 cm2) was

154

mixed with 200 µL PPP and warmed at 37 ℃ water bath for 15 min. Subsequently, 100 µL of mixture

155

(sample and PPP) was centrifuged, and the supernatant was mixed with 200 µL of prewarmed PT

156

reagents. The elapsed time from the addition of PT until blood clotting was recorded as PT value. When

157

TT was tested, a procedure similar to that of PT measurement was performed, except that the amount of

158

TT reagent was 100 µL. APTT was measured according to the TT test method, except for the 100 µL of

159

CaCl2 (0.025mol/L) required to initiate clotting. PPP (control group) was also evaluated by using these

160

methods. Each test was conducted at least three times.

161

2.6 Platelet aggregation

162

Anticoagulant whole blood was centrifuged at 1500 rpm for 15 minutes, and the platelet-rich plasma

163

(PRP) was aspirated using a straw. Approximately 200 µL PRP was added to the CS-NM/NACS-NM (1

164

x 1 cm2) and incubated at 37 ℃ for 1 h. To eliminate the surface adhesion of blood platelet on NACS-

165

NM/CS-NM, the samples were gently washed three times by a gradient series of ethanol (50%, 75%,

166

85% and 100%). Finally, the samples were immersed in 2.5% glutaraldehyde fixation fluid overnight,

167

dried and observed under SEM.

168

2.7 Fluorescence intensity (FI) of Ca2+

169

Anticoagulant whole blood was obtained and centrifuged at 1200 x g for 20 min. The upper plasma was

170

aspirated and centrifuged at 1200 x g for 15 min again. The bottom platelets were transferred into an

171

EP tube containing 10 µL Fluo-4 AM. After incubation at 37 ℃ for 15 min, the CS-NM/NACS-NM (1 x

172

1 cm2) was added, and the mixtures were incubated for another 15 min. Subsequently, 0.1% Trion –

ACS Paragon Plus Environment

Biomacromolecules 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

173

100 was added into each EP tube with severe concussion for 5 min. Each EP tube was centrifuged with

174

1200 x g at 4 ℃ for 5 min and 100 µL of supernatant was added into the black 96-well plates. The

175

Ex/Em = 485 nm/505 nm wavelength was evaluated by a microplate reader.

176

2.8 Statistical analysis

177

All data were expressed as the mean ± standard deviation. The significance of differences was

178

determined by one-way ANOVA. Results were considered significant at P